Important Notice: We are committed to providing you with a safe environment to do business, in accordance with all the health & safety guidelines set out by the local authorities. The event will be delivered with strict standards of health & safety precautionary measures including social distancing, contactless transactions and hygiene protocols. Learn More

Abu Dhabi’s G42 forms big data JV with Israeli defense company Rafael

   

Abu Dhabi’s G42 forms big data JV with Israeli defense company Rafael

Arab News
Israel and the UAE agreed to normalize relations in August 2020. (File/Reuters)
The joint venture will have a research and development site in Israel and will develop products for sectors including banking, health care and public safety

DUBAI: Abu Dhabi-based technology company Group 42 (G42) has formed a joint venture with Israel’s state-owned Rafael Advanced Defense Systems to commercialize artificial intelligence and big data technologies, the companies said on Monday.

The joint venture, called Presight.AI, will have a research and development site in Israel and will develop products for sectors including banking, health care and public safety, to be sold in Israel, the United Arab Emirates and internationally.

Israel and the UAE agreed to normalize relations in August, triggering a number of announcements from businesses stating their intention to cooperate across the two countries.

UAE Ambassador to Israel Mohamad Al-KHajja said the joint venture strengthened the relationship between Israel and the UAE and opportunities for bilateral economic growth.

G42 is an Abu Dhabi-based artificial intelligence and cloud computing company set up in 2018 which works with government and private clients. In September it became the first UAE company to open an international office in Israel.

UAE national security adviser Sheikh Tahnoon bin Zayed Al Nahyan is its chairman and a shareholder. Abu Dhabi’s sovereign fund Mubadala in November invested in G42 and last week US private-equity firm Silver Lake invested to help the company expand.

G42 rose to prominence last year as it led Phase III clinical trials of a vaccine developed by Sinopharm’s China National Biotec Group (CNBG) in the UAE and regional countries, as well as offering medical diagnostic services.

The joint venture agreement is subject to regulatory approvals by Israeli and UAE authorities.

View all News
Loading

Supporters & Partners

OFFICIALLY SUPPORTED BY

UAE Cyber Security Council

OFFICIAL GOVERNMENT CYBERSECURITY PARTNER

Dubai Electronic Security Center Logo

dp

OFFICIAL DISTRIBUTION PARTNER

ISPIRE

OFFICIALLY SUPPORTED BY

Telecommunications Regulatory Authority

Official Smart City Partner

Strategic Sponsors & Partners

Strategic Partner

huawei

Strategic Partner

  • Recorded Future

Platinum sponsors

digital14


PCYSYS

Secret Briefing Partner

rafael

Diamond sponsors

threat quotient

Attivo Networks - GISEC

XM Cyber - GISEC

Silver sponsors

bluvector

checkmarx-gisec

Darktrace-gisec

Recruitment Partner

cander-gisec

Training Partner

sans institute

Industry & Association Partner

Germany Association Partner

TeleTrusT

Supporting Association

CSFI

Supporting Association

ISC2

Supporting Association

OIC

Supporting Association

Russoft

Supporting Association

CSI Mumbai

India Pavilion Partner

Logo

Association Partner

techUJLogo

Knowledge Partner

Frost Logo

Association Partner

CyberWales

Exhibitors

 

Media Partners